Mouth: viral papilloma in Dogs (Canis) | Vetlexicon
canis - Articles

Mouth: viral papilloma

ISSN 2398-2942


Synonym(s): Oral papillomatosis; Canine oral warts

Introduction

  • Cause: canine papillomavirus type 1 (formerly canine oral papillomavirus) Papillomavirus.
  • Signs: multiple exophytic discrete papillomas (warts) in the mouth.
  • Diagnosis: clinical diagnosis, histology rarely required.
  • Treatment: surgical excision of larger lesions if causing clinical signs. Few medical treatments. Radiotherapy can be attempted for persistent uncomfortable lesions.
  • Prognosis: excellent. Papillomas in overwhelming majority of dogs spontaneously resolve within 6 weeks. Occasional cases can take longer. Very rarely papillomas are persistent and there are isolated reports that oral papillomas could progress to oral squamous cell carcinoma.

Presenting signs

  • Owner observes multiple papillomas in or around oral cavity Skin: oral papillomatosis 01 Skin: oral papillomatosis 02.
  • Dog is otherwise healthy and shows no clinical evidence of disease due to papillomas.

Geographic incidence

  • Worldwide.

Age predisposition

  • Most oral papillomas seen in dogs <1 year old.
  • Papillomas are very rare in old dogs and other diagnoses should be considered.
  • If a solitary oral papilloma is observed in an old dog, a diagnosis of squamous papilloma (a benign epithelial neoplasm not caused by viral infection) should be considered Skin: cutaneous papilloma.

Gender predisposition

  • None reported.

Breed/Species predisposition

  • None.

Public health considerations

  • None.
  • Canine papillomavirus type 1 Papillomavirus can only infect canids.

Pathogenesis

Etiology

Predisposing factors

General
  • Exposure to dogs with oral papillomas may predispose to disease, although this is usually only observed in larger dog colonies.
  • Dogs that have recovered from oral papillomas are protected from further papilloma development and this disease is seen in young dogs that have not been previously exposed to the papillomavirus.
  • Immunosuppression will not usually predispose to disease development but may allow the development of a greater number and size of the lesions and may delay spontaneous regression.

Pathophysiology

  • Microtrauma in the oral cavity allows canine papillomavirus type 1 access to the basal cells of the epithelium. Papillomaviruses have a tropism for squamous epithelial tissues.
  • The papillomavirus infects basal cells and, as part of a productive infection, stimulates massive hyperplasia of keratinocytes.
  • This hyperplasia causes marked thickening of the epidermis.
  • The thickened epidermis folds resulting in an exophytic lesion within the mouth.
  • The characteristic 'cauliflower' appearance of the papillomas is caused by the irregular folding of the hyperplastic epithelium.
  • Early in the infection, the dog produces antibodies against canine papillomavirus type 1. Although these antibodies prevent additional papilloma development, they do not cause papilloma regression.
  • Papilloma regression is dependent on a cell-mediated immune response which develops after a variable amount of time.
  • Once the cell-mediated immune response has been initiated, papilloma regression is rapid.
  • The dog is subsequently protected from papilloma development, although some evidence suggests a high proportion of dogs continue to have sub-clinical infection by canine papillomavirus type 1.

Timecourse

  • Experimental infection reveals the incubation period is 4-8 weeks.
  • The typical time to regression of the papillomas is also 4-8 weeks.
  • However, regression in some cases can take as long as 6 months.
  • In humans, around a quarter of cutaneous viral papillomas take over a year before spontaneous regression and even when persistence of the papillomas is prolonged, eventual regression should still be expected.

Epidemiology

  • The epidemiology of infection is poorly understood.
  • Currently it is believed that both dogs with oral papillomas and those without visible papillomas can shed infectious virus particles.
  • The rate of shedding of papillomavirus from a dog with visible papillomas is much higher than a dog without oral papillomas.

Diagnosis

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Treatment

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Prevention

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Outcomes

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Further Reading

Publications

Refereed papers

  • Recent references from PubMed and VetMedResource.
  • Szczepanek A, Bertran J, Shiomitsu K et al (2024) Successful definitive radiation treatment of refractory canine oral papillomatosis. Vet Radiol Ultrasound (online ahead of print) PubMed.
  • Rich N, Duclos D & Yuan H (2021) Management of severe, progressive oral papillomatosis in a dog with CO2 laser ablation and canine papillomavirus L1 immunisation. Vet Rec 9 (4), e168.
  • Regalado Ibarra A M, Legendre L & Munday J S (2018) Malignant Transformation of a Canine Papillomavirus Type 1-Induced Persistent Oral Papilloma in a 3-Year-Old Dog. J Vet Dent 35 (2), 79-95 PubMed.
  • Richman A W, Kirby A L, Rosenkrantz W & Muse R (2017) Persistent papilloma treated with cryotherapy in three dogs Vet Derm 28 (6), 625-e154 PubMed.
  • Uwagie-Ero E A, Abiaezute C N, Odigie E A & O'kwu A J (2017) Management of canine papillomatosis using oral acyclovir - a case report. Int J Vet Sci 6 (4), 187-190 Research Gate.
  • Lange C E & Favrot C (2011) Canine papillomaviruses. Vet Clin North Am Small Anim Pract 41 (6), 1183-1195 PubMed.
  • Lange C E, Zollinger S, Tobler K et al (2011) Clinically healthy skin of dogs is a potential reservoir for canine papillomaviruses. J Clin Microbiol 49 (2), 707-709 PubMed.
  • Favrot C, Olivry T, Werner A H et al (2005) Evaluation of papillomaviruses associated with cyclosporine-induced hyperplastic verrucous lesions in dogs. Am J Vet Res 66 (10), 1764-1769 PubMed.
  • Ghim S, Newsome J, Bell J et al (2000) Spontaneously regressing oral papillomas induce systemic antibodies that neutralize canine oral papillomavirus. Exp Mol Pathol 68 (3), 147-151 PubMed.
  • Nicholls P K, Klaunberg B A, Moore R A et al (1999) Naturally occurring, nonregressing canine oral papillomavirus infection: host immunity, virus characterization, and experimental infection. Virology 265 (2), 365-374 PubMed.
  • Bell J A, Sundberg J P, Ghim S J et al (1994) A formalin-inactivated vaccine protects against mucosal papillomavirus infection: a canine model. Pathobiology 62 (4), 194-198 PubMed.
  • Sundberg J P, Smith E K, Herron A J et al (1994) Involvement of canine oral papillomavirus in generalized oral and cutaneous verrucosis in a Chinese Shar Pei dog. Vet Pathol 31 (2), 183-187 PubMed.
  • Watrach A M, Small E & Case M T (1970) Canine papilloma: progression of oral papilloma to carcinoma. J Natl Cancer Inst 45 (5), 915-920 PubMed.

Other sources of information

  • Head K W, Else R W & Dubielzig R R (2002) Tumors of the Alimentary Tract. In: Tumors in Domestic Animals. 4th edn. Iowa State Press, USA.